Physician profile

Jense Benjamin

Family Medicine · Forney, TX

NPI 1205943263

$1,682.64

in general payments reported to CMS, 2019-2025

15 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$118.07

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals Lp $569.25 2019-2021
Boehringer Ingelheim Pharmaceuticals, INC. $219.54 2019-2020
Amarin Pharma, INC. $173.06 2019-2020
Novo Nordisk INC $138.71 2019-2020
Abbott Laboratories $100.70 2023-2024 Freestyle Libre 3
Kowa Pharmaceuticals America, INC. $99.86 2019-2020
Glaxosmithkline, LLC. $93.08 2019-2020
Janssen Pharmaceuticals, INC $74.20 2019
Merck Sharp & Dohme LLC $57.68 2019-2020
Pfizer INC. $46.25 2019-2020
Amgen INC. $32.80 2020
Sanofi-Aventis U.S. LLC $25.14 2019-2020
Arbor Pharmaceuticals, INC. $19.66 2019
Exact Sciences Corporation $17.37 2023 Cologuard Collection Kit
Allergan, INC. $15.34 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jense Benjamin

$1,682.64

in general payments reported 2019-2025

Years
2019-2024
Top company
Astrazeneca Pharmaceuticals Lp

https://glasscript.com/doctor/327098/jense-benjamin

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.